The limited treatment options available in veterinary clinics, as compared to human clinics, led me to pursue research instead of seeing patients. I've been working on evaluating the cytotoxicity of drugs on primary immune cells and tumor cells. My master's project, which focused on the anticancer effects of repurposed drugs, further piqued my curiosity about how innate immunity impacts cancer treatment. This also led me to question the use of immunodeficient mice for cancer research. Currently, I am studying the significance of NK cells in treating solid tumors with the long-term research goal of developing CAR-NK cell therapy.
